News and features

Epistem Holdings Plc (the "Company"), the biotechnology company which
commercialises adult stem cells in the areas of oncology and gastrointestinal
diseases, announced today that it has raised £1,065,703.78 by a placing of
653,806 Ordinary Shares of £0.015 each at an issue price of £1.63 per share, the
mid market price at the time the placing was agreed....

20/11/2007

Epistem plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its plucked hair biomarker platform will be presented at the joint international meeting of the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and European Organisation for Research and Treatment of Cancer (EORTC) being held in San Francisco, California, from October 22nd -26th 2007....

25/10/2007

Epistem (LSE:EHP) announced today that it has completed the first year of mucositis efficacy-testing services for potential biodefense drugs, and are about to...

20/9/2007

Epistem Plc (LSE: EHP), the UK epithelial stem cell company, announced today that it had entered into feasibility studies with AstraZeneca to use its proprietary plucked hair biomarker technology...

22/5/2007

Epistem Holdings Plc.
Fundraising and Placing by Teather and Greenwood
2.5m of new Ordinary Shares at 124 pence per share

4/4/2007